Successful dose reduction of dupilumab in atopic dermatitis

Br J Dermatol. 2023 Apr 20;188(5):678-679. doi: 10.1093/bjd/ljad011.

Authors

Michael R Ardern-Jones^{1

2}, Emily E Buchanan², Samba Njungu¹, Daniel O'Driscoll¹

Affiliations

¹ Department of Dermatology, University Hospital Southampton NHS Foundation Trust.
² Clinical Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, Hampshire SO16 1DU, UK.

PMID: 36662536
DOI: 10.1093/bjd/ljad011

No abstract available

MeSH terms

Antibodies, Monoclonal / therapeutic use
Antibodies, Monoclonal, Humanized / therapeutic use
Dermatitis, Atopic* / drug therapy
Drug Tapering
Humans
Severity of Illness Index
Treatment Outcome

Substances

dupilumab
Antibodies, Monoclonal, Humanized
Antibodies, Monoclonal